Squamous cell carcinoma of the lung secondary prevention

Jump to navigation Jump to search

Squamous Cell Carcinoma of the Lung Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Squamous Cell Carcinoma of the Lung from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Squamous cell carcinoma of the lung secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Squamous cell carcinoma of the lung secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Squamous cell carcinoma of the lung secondary prevention

CDC on Squamous cell carcinoma of the lung secondary prevention

Squamous cell carcinoma of the lung secondary prevention in the news

Blogs on Squamous cell carcinoma of the lung secondary prevention

Directions to Hospitals Treating Squamous cell carcinoma of the lung

Risk calculators and risk factors for Squamous cell carcinoma of the lung secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]

Overview

The secondary prevention of non-small cell lung cancer is based on the stage of non-small cell lung cancer at diagnosis. Secondary prevention includes chest CT imaging along with a periodic evaluation of alert signs in second-hand smokers or active smokers.

Secondary Prevention

Measures for secondary prevention for non-small cell lung cancer depends on the stage of non-small cell lung cancer at diagnosis.[1][2][3]

  • The National Comprehensive Cancer Network (NCCN) recommends the following:
    • Low-dose helical computed tomography (CT) scanning is the standard screening modality for early detection.
    • Annual screening (patients with high-risk), early detection is discontinued if patients have been 15 years without smoking.

References

  1. Tominaga S (2000). "[Prevention of lung cancer--primary and secondary prevention]". Nippon Rinsho (in Japanese). 58 (5): 1149–52. PMID 10824565.
  2. National Cancer Institute: PDQ® Lung Cancer Prevention. Bethesda, MD: National Cancer Institute. Date last modified 02/16/2016. Available at: http://www.cancer.gov/types/lung/hp/lung-prevention-pdq. Accessed
  3. Van't Westeinde SC, van Klaveren RJ (2011). "Screening and early detection of lung cancer". Cancer J. 17 (1): 3–10. doi:10.1097/PPO.0b013e3182099319. PMID 21263260.


Template:WikiDoc Sources